<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Vupputuri, Suma</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Lifetime Risk of Nephropathy and Its Progression May Be Greater than Previously Reported</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">22-23</style></pages><abstract><style  face="normal" font="default" size="100%">The current worldwide prevalence of diabetes is estimated to be 366 million. One-third of these cases progress to nephropathy, a major cause of cardiovascular disease and end-stage renal disease. This article describes the prevalence, incidence, and progression of nephropathy and identified demographic and clinical characteristics that are associated with progression in a US population-based sample.</style></abstract><number><style face="normal" font="default" size="100%">9</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>